Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene
This study is currently recruiting participants.
Verified February 2013
by Robert Bosch Gesellschaft für Medizinische Forschung mbH
Study NCT01289756 Information provided by Robert Bosch Gesellschaft für Medizinische Forschung mbH
First Received on February 2, 2011. Last Updated on February 7, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anovulation
More general conditions related to this trial
Adnexal Diseases
Endocrine System Diseases
Genital Diseases, Female
Gonadal Disorders
Ovarian Diseases
Interventions listed in this trial
Clomiphene
clomiphene and paroxetine
clomiphene and clarithromycin
Additional drug interventions recognized in this trial
Clarithromycin
Paroxetine
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Enzyme Inhibitors
Estrogen Antagonists
Estrogen Receptor Modulators
Fertility Agents
Fertility Agents, Female
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Protein Synthesis Inhibitors
Psychotropic Drugs
Reproductive Control Agents
Selective Estrogen Receptor Modulators
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Robert Bosch Gesellschaft für Medizinische Forschung mbH
Back to top of Main Content
